Market Update (NYSE:PFE): Price Movements, Clinical Trial Results, and Solid Financial Reports – Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array

March 05, 2014 at 13:14 PM EST

[PR Newswire] – Today, Analysts Review released its analysts’ notes regarding Pfizer Inc. (PFE), Dendreon Corp. (DNDN), DepoMed Inc. (DEPO), Globus Medical, Inc. (GMED), and Array BioPharma, Inc. (ARRY). On March 3, 2014, . . . → Read More: Market Update (NYSE:PFE): Price Movements, Clinical Trial Results, and Solid Financial Reports – Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array Similar Articles: Company Update – Cisco Systems Inc. (NASDAQ:CSCO) – Cisco CEO Chambers: Internet of Everything a $19T market, Bloomberg reports The Boeing Company (NYSE:BA) – Boeing reports 17 new orders in weekly update Stock market seasonality mid-year update

Pfizer Inc (NYSE:PFE) [PR Newswire] – Today, Analysts Review released its analysts’ notes regarding Pfizer Inc. (PFE), Dendreon Corp. (DNDN), DepoMed Inc. (DEPO), Globus Medical, Inc. (GMED), and Array BioPharma, Inc. (ARRY). On March 3, 2014, Pfizer Inc.’s (Pfizer) stock decreased 0.40% to end the day at $31.98, compared to the previous day’s closing price at $32.11. Pfizer’s stock decreased 0.03% over the past three trading days, compared to the Dow Jones Industrial Average which went down … [visit site to read more]